In this podcast, experts in DED management share pearls and advice for optimizing a patient's ocular surface by addressing MGD.
In the third and final episode in this series about meibomian gland dysfunction (MGD), George Waring IV, MD; Tal Raviv, MD; Gregory Parkhurst, MD; and Bobby Saenz, OD, discuss patient education-one of the most important aspects to successfully treat MGD in your practice. The physicians share insights into their experience educating patients efficiently and presenting their treatment recommendations with confidence.
In the second episode in this series about meibomian gland dysfunction (MGD), George Waring IV, MD; Gregory Parkhurst, MD; Bobby Saenz, OD; and Douglas Devries, OD, discuss how far we've come from treating MGD with warm compresses and cold manual expression alone. They also discuss which treatments they prefer and the decision-making process that led them to their current solution for MGD, reinstating the importance of addressing these blocked glands.
Our understanding of ocular surface health has increased exponentially in recent years, but the growing wealth of knowledge can sometimes be difficult to succinctly apply in the clinic. George Waring IV, MD; Tal Raviv, MD; and Doug Devries, OD, discuss the overarching role of meibomian glands in ocular surface health and pre-surgical measurements, how they impact patients' vision, and how to effectively evaluate the glands. This is the first of three podcasts in this series.